Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot SMART trial of ibuprofen and activated carbon dressings for pain in venous leg ulcers
ACTRN12617001632381Phase 4Terminated
- Sponsor
- Queensland University of Technology
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ibuprofen and activated charcoal in stasis ulcer (3 arms), sponsored by Queensland University of Technology. Primary endpoint: Pain numerical rating scale. Started Aug 2018; status: terminated.
02
Drugs
ibuprofenactivated charcoal
03
Conditions
stasis ulcer
Beyond the preview
Go deeper on ACTRN12617001632381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001632381.